The Globe and Mail reports in its Tuesday, March 26, edition that National Bank Financial analyst Vishal Shreedhar thinks Lassonde Industries' turnaround "remains on track." The Globe's David Leeder writes in the Eye On Equities column that maintaining his "favourable view" on Lassonde and his "outperform" recommendation, Mr. Shreedhar boosted his share target to $174 from $173 based on his "slightly" higher estimates. Analysts on average target the shares at $174.67. Mr. Shreedhar says in a note: "We remain supportive of Lassonde's priority to maximize the performance of existing businesses. ... We consider Lassonde to be a company with meaningful turnaround potential, predominantly within the U.S. operations. We estimate Lassonde's U.S. operations generated an EBIT margin of 3 per cent in 2023, from flattish in 2022 (historical range of 6 to 9 per cent; 2012-2017). If the U.S. business returns to historical EBIT margins, we estimate meaningful upside to our 2026 estimates. Though there remains near-term uncertainty surrounding consumer health, cost inflation and operational performance, we hold a positive view given favourable valuation and expectations of improving performance (pricing, Project Eagle, etc.)."